Aequus Pharmaceuticals Stock Shares Outstanding
| AQS Stock | CAD 0.01 0.01 50.00% |
Aequus Pharmaceuticals fundamentals help investors to digest information that contributes to Aequus Pharmaceuticals' financial success or failures. It also enables traders to predict the movement of Aequus Stock. The fundamental analysis module provides a way to measure Aequus Pharmaceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Aequus Pharmaceuticals stock.
Aequus |
Aequus Pharmaceuticals Company Shares Outstanding Analysis
Aequus Pharmaceuticals' Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current Aequus Pharmaceuticals Shares Outstanding | 132.63 M |
Most of Aequus Pharmaceuticals' fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Aequus Pharmaceuticals is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
| Competition |
Based on the latest financial disclosure, Aequus Pharmaceuticals has 132.63 M of shares currently outstending. This is 26.53% lower than that of the Pharmaceuticals sector and 66.98% lower than that of the Health Care industry. The shares outstanding for all Canada stocks is 76.8% higher than that of the company.
Aequus Shares Outstanding Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Aequus Pharmaceuticals' direct or indirect competition against its Shares Outstanding to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Aequus Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Aequus Pharmaceuticals by comparing valuation metrics of similar companies.Aequus Pharmaceuticals is currently under evaluation in shares outstanding category among its peers.
Aequus Fundamentals
| Return On Equity | -15.7 | ||||
| Return On Asset | -1.53 | ||||
| Operating Margin | (3.69) % | ||||
| Current Valuation | 7.18 M | ||||
| Shares Outstanding | 132.63 M | ||||
| Shares Owned By Insiders | 14.68 % | ||||
| Number Of Shares Shorted | 834 | ||||
| Price To Earning | (1.85) X | ||||
| Price To Book | 24.39 X | ||||
| Price To Sales | 1.61 X | ||||
| Revenue | 254.9 K | ||||
| Gross Profit | 220.83 K | ||||
| EBITDA | (2.68 M) | ||||
| Net Income | (2.96 M) | ||||
| Cash And Equivalents | 1.46 M | ||||
| Cash Per Share | 0.02 X | ||||
| Total Debt | 5.06 M | ||||
| Debt To Equity | 248.30 % | ||||
| Current Ratio | 4.37 X | ||||
| Book Value Per Share | (0.05) X | ||||
| Cash Flow From Operations | (2.29 M) | ||||
| Short Ratio | 0.02 X | ||||
| Earnings Per Share | (0.01) X | ||||
| Target Price | 2.52 | ||||
| Beta | -0.17 | ||||
| Market Capitalization | 663.17 K | ||||
| Total Asset | 1.09 M | ||||
| Retained Earnings | (32.68 M) | ||||
| Working Capital | (4.36 M) | ||||
| Net Asset | 1.09 M |
About Aequus Pharmaceuticals Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Aequus Pharmaceuticals's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Aequus Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Aequus Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Aequus Stock Analysis
When running Aequus Pharmaceuticals' price analysis, check to measure Aequus Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aequus Pharmaceuticals is operating at the current time. Most of Aequus Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Aequus Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aequus Pharmaceuticals' price. Additionally, you may evaluate how the addition of Aequus Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.